Ibrutinib: searching for a partner drug.
| Autor: | Kater AP; Department of Hematology and Lymphoma and Myeloma Center, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam 1105AZ, Netherlands. Electronic address: a.p.kater@amc.nl., Brown JR; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Lancet. Oncology [Lancet Oncol] 2019 Jan; Vol. 20 (1), pp. 3-5. Date of Electronic Publication: 2018 Dec 03. |
| DOI: | 10.1016/S1470-2045(18)30861-1 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|